INFLUENCE OF GADOLINIUM CHELATES ON P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE LIVER

被引:0
|
作者
BAUER, H
NEGISHI, C
WEINMANN, HJ
机构
[1] SAITAMA MED SCH,DEPT RADIOL,MOROYAMA,SAITAMA 35004,JAPAN
[2] SCHERING AG,RES LABS,BERLIN,GERMANY
关键词
GADOLINIUM; RAT LIVER; MAGNETIC RESONANCE SPECTROSCOPY; CONTRAST MEDIA; P-31; STUDIES;
D O I
10.1097/00004424-199408000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. The potential of gadolinium compounds (Gd-ethoxybenzyl-DTPA [Gd-EOB-DTPA], gadopentetate dimeglumine [Gd-DTPA], and Gd-chloride [GdCl3]) to enhance the signals from intracellular phosphorus-31 nuclei in the liver was investigated. METHODS. After intravenous administration of Gd-EOB-DTPA, Gd-DTPA, and GdCl3 to rats, liver phosphorus metabolites (inorganic phosphate [Pi], phosphomonoester [PME], and adenosine triphosphate [ATP]) were measured by phosphorus-31 magnetic resonance spectroscopy (MRS). The dose of each compound was 0.2 mmol Gd/kg. Saline was used as a control. RESULTS. The intensities of the phosphorus metabolite signals in the liver showed only minor changes after administration of Gd-DTPA and GdCl3, but increased after Gd-EOB-DTPA. The signals of Pi and PME were enhanced more than those of ATP. The alpha peak of ATP increased by 21.7%, Pi by 61.2%, and PME by 49.2%. CONCLUSIONS. The signal intensities of the phosphorus metabolites in the liver were not influenced by GdCl3. Using Gd-DTPA, only a slight enhancement could be detected. The greatest enhancement was observed with Gd-EOB-DTPA, which has access to the phosphorus metabolites within the hepatocytes. The injection of Gd-EOB-DTPA results in better detectability of the Pi signal.
引用
收藏
页码:752 / 757
页数:6
相关论文
共 50 条
  • [1] INVIVO P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN LIVER-DISEASE
    BRINKMANN, G
    MELCHERT, U
    FORGER, K
    WUNSCHBINDER, F
    HEIDEMANN, H
    ENGEMANN, R
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1990, 153 (02): : 204 - 208
  • [2] P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN RENAL ISCHEMIA
    RATCLIFFE, PJ
    ENDRE, ZH
    BLACKLEDGE, MJ
    LEDINGHAM, JGG
    RADDA, GK
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (04) : 578 - 578
  • [3] P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF MESENTERIC ISCHEMIA
    KASS, DA
    BANVILLE, DL
    GOODING, CA
    JAMES, TL
    MAGNETIC RESONANCE IN MEDICINE, 1987, 4 (01) : 83 - 87
  • [4] P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF DUCHENNES MYOPATHY
    WEIKL, A
    GOHL, K
    OPPELT, A
    BACHMANN, K
    ZEITSCHRIFT FUR KARDIOLOGIE, 1987, 76 : 31 - 31
  • [5] ASSESSMENT OF HUMAN-LIVER DISEASE BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    OBERHAENSLI, RD
    RAJAGOPALAN, B
    TAYLOR, DJ
    RADDA, GK
    CLINICAL SCIENCE, 1986, 71 : P82 - P82
  • [6] STUDY OF HUMAN LIVER-DISEASE WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    OBERHAENSLI, R
    RAJAGOPALAN, B
    GALLOWAY, GJ
    TAYLOR, DJ
    RADDA, GK
    GUT, 1990, 31 (04) : 463 - 467
  • [7] ASSESSMENT OF HUMAN-LIVER METABOLISM BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    OBERHAENSLI, RD
    GALLOWAY, GJ
    TAYLOR, DJ
    BORE, PJ
    RADDA, GK
    BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (703): : 695 - 699
  • [8] P-31 NUCLEAR MAGNETIC-RESONANCE (P-31 NMR) SPECTROSCOPY IN PEDIATRIC NEUROMUSCULAR DISORDERS
    HARCKE, HT
    MARKS, HG
    HARTZELL, CR
    CHANCE, B
    WARNELL, RA
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P47 - P47
  • [9] ASSESSMENT OF RENAL VIABILITY BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    BRETAN, PN
    VIGNERON, DB
    JAMES, TL
    WILLIAMS, RD
    HRICAK, H
    JUENEMANN, KP
    YEN, TSB
    TANAGHO, EA
    JOURNAL OF UROLOGY, 1986, 135 (04): : 866 - 871
  • [10] P-31 MAGNETIC-RESONANCE MUSCLE SPECTROSCOPY IN FIBROMYALGIA - REPLY
    JACOBSEN, S
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (11) : 1985 - 1986